Dr Anjali Ajgaonker

Anjali is a seasoned global project leader with nearly two decades of experience driving clinical research and development across pharma, biotech, CROs, and med-tech. She earned her PhD in Neurobiology and Neurosciences from Royal Holloway, University of London, and holds an MBA in Finance and Strategy Management from Welingkar Institute of Management. Her career spans leadership roles at ICON plc, Cipla, and Meril, where she managed global clinical operations, spearheaded large-scale multi-country trials, and led cross-functional teams to deliver programs with precision in timelines, quality, and budget. Earlier in her career, she contributed to pivotal clinical research operations at Sanofi, GSK, Quintiles, and Boehringer Ingelheim. Anjali combines scientific depth with strategic management expertise, demonstrated through her ability to bridge clinical science, operational execution, and financial oversight. Certified in Six Sigma and trained in Generative AI applications, she continues to advance innovation in global drug development and project management, with a focus on accelerating access to new therapies worldwide.